Survey Suggests India Red Tape Sends R&D Investment Elsewhere In Asia
This article was originally published in PharmAsia News
Executive Summary
Blaming red tape, many drug manufacturers operating in India are shifting their research-and-development investments to other nations, a recent survey has shown.